Drug intelligence / Profile preview

OraVital CDLx Rinse

Development stage: Unknown
Lead developer: OraVital
Modality: Small Molecules
Administration: Topical

Overview

**OraVital CDLx Rinse** is a commercially available, alcohol-free oral antimicrobial maintenance rinse developed by OraVital. It combines acidified sodium chlorite, described as stabilized chlorine dioxide, with xylitol to reduce odor-associated gram-negative anaerobic oral bacteria and volatile sulfur compounds, while xylitol supports suppression of cariogenic bacteria. The rinse is marketed for daily oral-health maintenance in people with halitosis, gingivitis, periodontal disease, and tooth-decay risk; mint and unflavoured versions are available. ([maxill.com](https://www.maxill.com/ca/our-products/oral-care/oral-rinses/oravital-r-cdlx-rinse.html))

Brand names: OraVital CDLx Rinse
Other names: CDLx RinseOraVital CDLx

Beyond the preview

Go deeper on OraVital CDLx Rinse.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OraVital CDLx Rinse.

Explore the full profile